Save up -80% on Ticagrelor
|Note: this is a drug discount program, not an insurance plan.|
|RX BIN: 015558||RX PCN: HT||Group ID: DDN6600||Card Holder ID: DDN6600|
|Pharmacists and Patients support.|
2019 Price of Brilinta
|$391.05||60 tablets/90 mg|
|price without discount in nearest pharmacy. Price may vary.|
We offer free Brilinta coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your manufacturer copay card in most local pharmacies to get a discount on Ticagrelor every time. What are you waiting for? Claim your prescription drug card now!
Get your Prescription
It’s safe and free
Buy drugs in pharmacy
Save money each time
Ticagrelor volume of distribution
The absolute bioavailability of ticagrelor is estimated at 36%, and the steady-state volume of distribution of ticagrelor is 88 L.
Discount Cards 16,000+
Clients Benefit 29%
Total savings $4,735,080
What is Ticagrelor
Ticagrelor (trade name Brilinta in the US, Brilique and Possia in the EU) is a platelet aggregation inhibitor produced by AstraZeneca. Unlike clopidogrel, ticagrelor is not a prodrug and does not require metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010. The drug was approved by the US Food and Drug Administration on July 20, 2011.
Ticagrelor mechanism of action
Like the thienopyridines prasugrel, clopidogrel and ticlopidine, ticagrelor blocks adenosine diphosphate (ADP) receptors of subtype P2Y12. In contrast to the other antiplatelet drugs, ticagrelor has a binding site different from ADP, making it an allosteric antagonist, and the blockage is reversible. Moreover, the drug does not need hepatic activation, which might work better for patients with genetic variants regarding the enzyme CYP2C19 (although it is not certain whether clopidogrel is significantly influenced by such variants).
Dosage forms of Ticagrelor
(1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-D)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol AZD 6140
Humans and other mammals
Indication of Ticagrelor
For the prevention of thrombotic events (for example stroke or heart attack) in patients with acute coronary syndrome or myocardial infarction with ST elevation.
RX24 Drugs Disclaimer: consult your healthcare provider before buying a Ticagrelor on prescription or using an RX manufacturer savings coupon. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.
Get lower price on Ticagrelor now!
What is Brilinta?
Brilinta helps prevent platelets from sticking together in your blood and forming a blood clot. An unwanted blood clot can occur in certain conditions of the heart or blood vessels. Brilinta is used to reduce the risk of stroke or serious heart problems after a heart attack or severe chest pain (angina).
You should not use Brilinta if you have severe liver disease, any active bleeding (including bleeding stomach ulcer), or a history of bleeding in the brain. Do not use this medicine immediately before cardiac bypass surgery (coronary artery bypass or CABG).
You may need to stop using Brilinta for a short time before surgical or dental work to prevent excessive bleeding. Do not stop taking Brilint without first discussing your doctor, even if you have signs of bleeding. Stopping this medication may increase the risk of heart attack or stroke. Brilinta can cause bleeding more easily, which can be heavy or life threatening. Avoid actions that may increase the risk of bleeding or injury.
Many medications (including some over-the-counter and herbal products) can cause serious medical problems if you take them with Brilinta. It is very important to tell your doctor about all the medicines you have recently used.